Interius BioTherapeutics

PHILADELPHIA, PA · Founded 2019 · CIK 0001807811 · Biotech · Acquired

In vivo CAR-T cell engineering platform using targeted viral vectors

interiustx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$118M
4 Form D · Jun 2024
28 months since last filing
Contracts
—
No federal contracts on record
Patents
40
4 granted · 36 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,575,000
Private capital raisedForm D · SEC$43,625,657
Private capital raisedForm D · SEC$21,451,331
Private capital raisedForm D · SEC$51,432,536
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2810Edgewise Therapeutics—$120M
2811Ensoma—$120M
2812A2 Biotherapeutics—$119M
2813Interius BioTherapeutics—$118M
2814TAMBO, INC.——
2815Diapin Therapeutics LLC——
2816Mineralys Therapeutics, Inc.—$118M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • Bihua ChenDirector
  • Lori ForrestExecutive Officer
  • Saar GillExecutive Officer
  • Philip JohnsonDirector · Executive Officer
  • Philip Johnson, M.D.Director · Executive Officer
  • Tomas KiselakDirector
  • Benjamin LundDirector
  • Dora MitchellExecutive Officer
  • Leon MoulderDirector
  • Leon Moulder, Jr.Director
  • Bruce PeacockDirector · Executive Officer

Patents

USPTO · 4 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.